The Effect of Low HER2 Expression on Outcomes in Patients With Metastatic HR+ Breast Cancer Treated With a CDK4/6 Inhibitor and Endocrine Therapy
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
The Breast
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
The effect of low HER2 expression on treatment outcomes in metastatic hormone receptor positive breast cancer patients treated with a combination of a CDK4/6 inhibitor and endocrine therapy: A multicentric retrospective study
Breast 2023 Aug 01;70(xx)56-62, E Caliskan Yildirim, E Atag, E Coban, O Umit Unal, A Celebi, M Keser, M Uzun, M Keskinkilic, E Tanrikulu Simsek, M Sari, T YavuzsenFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.